Fate Therapeutics (FATE) PT Raised to $33 at Wedbush
Tweet
Share
E-mailGet Alerts FATE Hot Sheet
Price: $4.54 -5.02%
Rating Summary:
9 Buy, 15 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 11 | New: 13
Rating Summary:
9 Buy, 15 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 11 | New: 13
Join SI Premium – FREE
Wedbush analyst David Nierengarten raised the price target on Fate Therapeutics (NASDAQ: FATE) to $33.00 (from $29.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Quest Diagnostics (DGX) PT Raised to $145 at Evercore ISI
- UBS Downgrades Gujarat State Petronet (GUJS:IN) to Sell
- SK Innovation Co Ltd (096770:KS) PT Lowered to KRW120,000 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
